GHC is committed in the fight against MS!

Multiple sclerosis is a disease of the central nervous system in which the body’s immune system attacks the protective sheath (myelin) that covers the nerves. Damage to the myelin disrupts the flow of information in the brain and between the brain and the body. In some patients, the nerves may deteriorate and the irreversible damage can affect sensory and motor skills such as eyesight and walking.

Multiple Sclerosis Types and Specialized Treatment

Multiple sclerosis affects an estimated 2.5 million people worldwide. A disorder of young adults, the disease predominantly targets women with varying levels of severity and symptoms that range from fatigue and mood disturbances to pain, cognitive loss, and motor or sensory impairment.

There are several multiple sclerosis subtypes. Up to 75% of cases begin with a relapsing-remitting (RRMS) course, which involves acute attacks that are separated in time, with full or partial recovery. The primary-progressive (PPMS) subtype involves a progression of disability with occasional plateaus and temporary minor improvements. Approximately 6-10% of people with multiple sclerosis appear to have PPMS at diagnosis. The secondary-progressive (SPMS) subtype is characterized by progression of the disease at a variable rate.

The cause of the disease is unknown, but it is believed that environmental factors or an infection can trigger multiple sclerosis in an individual who is genetically predisposed to respond.

While no therapy has shown to cure the disease, multiple sclerosis treatments can help manage the disease. The assessment of therapies remains difficult because of the lack of specific indicators for disease activity and unpredictable disease course, however, the goals are consistent in attempting to decrease the severity and duration of attacks, halt or reverse the disease, or provide symptomatic relief from complications of the disease. Types of multiple sclerosis treatment include a new focus on disease-modifying therapies, immunomodulators, corticosteroids, and other immunosuppressants.


Multiple Sclerosis Medications

  • Aubagio


Patient Support 1-855-MSOne2One (1-855-676-6326)

  • Avonex


Patient Support 1-800-456-2255


  • Betaseron


Patient Support 1-888-84-BAYER (1-888-842-2937).

  • Copaxone


Patient Support 1-800-887-8100

  • Extavia


Patient Support 1-888-NOW-NOVA (1-888-669-6682)

  • Gilenya


Patient Support 1-800-GILENYA (1-800-445-3692)

  • Novantrone

  • Rebif


Patient Support 1-877-447-3243.

  • Tecfidera


  • Tysabri


Patient Support 800.456.2255

  • Lemtrada
  • Ocrevus


Additional Resources

Multiple Sclerosis Foundation

The Multiple Sclerosis Foundation (MSF) helps individuals affected by multiple sclerosis maintain their health and well-being. MSF offers programs and support to keep those with multiple sclerosis self-sufficient and safe in their homes. They also provide educational programs to increase public awareness and understanding of their own disease. MSF offers support groups for people with MS and their families to share their experiences.

National Multiple Sclerosis Society

The National MS Society is a group of individuals whose mission is to “mobilize people and resources to drive research for a cure and to address the challenges of everyone affected by MS.” The National Multiple Sclerosis Society has a chapter in all 50 states and an online community to help those who have the disease. The National MS Society also offers hundreds of special events a year to engage participants to support their mission.